Ardena and RiboPro forge ‘strategic alliance’ to support RNA revolution 10-Jul-2023 By Isabel Cameron Contract development manufacturer of nanomedicines, Ardena, has joined forces with mRNA and LNP technology specialists RiboPro, to form a new strategic commercial alliance.
Recipharm’s Arranta Bio expands RNA process development capacity by 50% 09-Mar-2023 By Jane Byrne Arranta Bio, a Recipharm company, has doubled capacity at its Massachusetts facility for process development services supporting RNA therapeutics.
